ASSESSMENT OF THE PNEUMOCOCCAL VACCINATION PROGRAMME IN MANGISTAU REGION, KAZAKHSTAN
- Authors: Karibayeva IK1, Aimbetova GE1, Amireev SA1, Yeraliyeva LT1, Kyzayeva AD1, Akanov AA1, Tulebayev KA1, Turdaliyeva BC1, Grjibovski AM2,3,4
-
Affiliations:
- National Kazakh Medical University named after. S.D. Asfendiyarov
- Norwegian Institute of Public Health
- International School of Public Health, Northern State Medical University
- International Kazakh-Turkish University
- Issue: Vol 22, No 3 (2015)
- Pages: 32-39
- Section: Articles
- URL: https://journals.rcsi.science/1728-0869/article/view/17095
- DOI: https://doi.org/10.17816/humeco17095
- ID: 17095
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I K Karibayeva
National Kazakh Medical University named after. S.D. Asfendiyarov
G E Aimbetova
National Kazakh Medical University named after. S.D. Asfendiyarov
S A Amireev
National Kazakh Medical University named after. S.D. Asfendiyarov
L T Yeraliyeva
National Kazakh Medical University named after. S.D. Asfendiyarov
A D Kyzayeva
National Kazakh Medical University named after. S.D. Asfendiyarov
A A Akanov
National Kazakh Medical University named after. S.D. Asfendiyarov
K A Tulebayev
National Kazakh Medical University named after. S.D. Asfendiyarov
B C Turdaliyeva
National Kazakh Medical University named after. S.D. Asfendiyarov
A M Grjibovski
Norwegian Institute of Public Health; International School of Public Health, Northern State Medical University; International Kazakh-Turkish University
Email: andrej.grjibovski@gmail.com
старший советник Норвежского института общественного здравоохранения, г. Осло, Норвегия; директор Архангельской международной школы общественного здоровья СГМУ, г. Архангельск; профессор Международного казахско-турецкого университета
References
- Государственная программа развития здравоохранения Республики Казахстан «СаламаттыКазакстан» на 2011 - 2015 годы: Указ Президента Республики Казахстан от 29 ноября 2010 года № 1113. URL: http://online.zakon.kz/document/?doc_id=30861087 [дата обращения: 17.12.2014]
- Инфекции респираторного тракта у детей раннего возраста / под ред. Г.А. Самсыгиной. М.: Миклош, 2006. С. 187-250.
- Рациональная фармакотерапия детских заболеваний: руководство для практикующих врачей в 2 кн. / под общ. ред. А.А. Баранова, Н.Н. Володина, Г.А. Самсыгиной. М.: Литтерра, 2007. С. 451-468.
- Рекомендации расширенного заседания Совета экспертов на тему «Бремя пневмококковых заболеваний в России» // Вопросы современной педиатрии. 2009. Т. 8, № 2. C. 104 - 109.
- Сидоренко С.В., Лобзин Ю.В., Харит С.М., Королева И.С., Таточенко В.К. Пневмококковая инфекция и современные возможности ее профилактики - эпидемиологический обзор ситуации в мире и в России // Вопросы современной педиатрии. 2010. Т. 9, № 1. С. 54-61.
- Статистический сборник «Здоровье населения Республики Казахстан и деятельность организаций здравоохранения в 2008 году». Астана, 2009.
- Aguiar S.I., Brito M.J., Horacio A.N., Lopes J.P., Ramirez M., Melo-Cristino J. Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012 // Euro Surveill. 2014. Vol. 27. Р. 20750.
- American Academy of Pediatrics. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) // Pediatrics. 2010. Vol. 126. P. 186-190.
- Buckingham S.C. Incidence and etiologies of complicated pneumonic effusion in children 1996-2001 // Pediatr. Infect. Dis. J. 2003. Vol. 22. P. 499-504.
- Caierão J., Hawkins P., Santanna F.H., da Cunha G.R., d'Azevedo P.A., McGee L., Dias C. Serotypes and Genotypes of Invasive Streptococcus pneumoniaeBefore and After PCV10 Implementation in Southern Brazil // PLoS One. 2014. Vol. 30. e111129.
- Centers for Disease Control and Prevention. Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2008. MMWR Morb Mortal // Wkly Rep. 2008. Vol. 57. P. 1148-1151.
- De Wals P., Lefebvre B., Markowski F., Deceuninck G., Defay F., Douville-Fradet M., Landry M. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada // Vaccine. 2014. Vol. 32. P. 1501-1506.
- Juven T., Mertsola J., Waris M. et al. Etiology of community-acquired pneumonia in 254 hospitalized children // Pediatr. Infect. Dis. J. 2000. Vol. 19. P. 293-296.
- Lebel M.H., Kellner J.D., Ford-Jones E.L., et al. A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada // Clin. Infect. Dis. 2003. Vol. 36. P. 259-268.
- Lieu T.A., Ray G.T., Black S.B. et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children // JAMA. 2000. Vol. 283. P. 1460-1468.
- Lloyd A., Patel N., Scott D.A., Runge C., Claes C., Rose M. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects // Eur. J. Health Econ. 2008. Vol. 9. P. 7-15.
- Ndlangisa K.M., du Plessis M., Wolter N., de Gouveia L., Klugman K.P., von Gottberg A. GERMS-SA. Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines // PLoS One. 2014. Vol. 9. e107666.
- Poehling K.A., Talbot T.R., Griffin M.R., Craig A.S., Whitney C.G., Zell E. et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine // JAMA. 2006. Vol. 295. P. 1668-1674.
- Robinson K.A., Baughman W., Rothrock G., Barrett N.L., Pass M., Lexau C. et al. Active Bacterial Core Surveillance (ABCs) Emerging Infections Program Network. Epidemiology of invasive Streptococcus pneumoniaeinfections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era // JAMA. 2001. Vol. 285. P. 1729- 1735.
- Sinha A., Levine O., Knoll M.D., Muhib F., Lieu T.A. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis // Lancet. 2007. Vol. 369. P. 389-396.
- Tsigrelis C., Tleyjeh I.M., Huskins W.C., Lahr B.D., Nyre L.M., Virk A., Baddour L.M. Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota // Mayo Clin. Proc. 2009. Vol. 84. P. 871- 875.
- World Health Organization. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper // Wkly Epidemiol Rec. 2007. Vol. 82. P. 93-104.